AD Pharma Consult: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AD Pharma Consult
Largest movements
- Receivables within one year +€115,818
up €115,818 (+104%), from €110,890 to €226,707
of which Trade receivables: +€126,022
- Cash +€63,639
up €63,639 (+57.0%), from €111,641 to €175,280
mainly Net result for the year (+€426,824) and Other debts (+€166,448)
- Tangible fixed assets -€7,087
down €7,087 (-52.7%), from €13,441 to €6,354
of which Furniture and vehicles: -€7,015
- Other debts +€166,448
up €166,448 (+28,181%), from €591 to €167,039
- Tax, wage and social debts +€35,234
up €35,234 (+540%), from €6,522 to €41,756
- Reserves -€19,068
down €19,068 (-4.3%), from €445,892 to €426,824
- Accrued charges and deferred income -€14,993
no longer reported in 2025 (was €14,993)
- Gross operating margin +€180,672
up €180,672 (+46.9%), from €385,194 to €565,866
- Taxes +€46,073
up €46,073 (+51.0%), from €90,319 to €136,391
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €470,526 | €641,701 | +€171,175 | +36.4% |
| Fixed assets | 21/28 | €13,441 | €6,354 | -€7,087 | -52.7% |
| Tangible fixed assets | 22/27 | €13,441 | €6,354 | -€7,087 | -52.7% |
| Furniture and vehicles | 24 | €13,031 | €6,016 | -€7,015 | -53.8% |
| Other tangible fixed assets | 26 | €410 | €338 | -€72 | -17.6% |
| Current assets | 29/58 | €457,085 | €635,348 | +€178,263 | +39.0% |
| Amounts receivable within one year | 40/41 | €110,890 | €226,707 | +€115,818 | +104% |
| Trade receivables | 40 | €95,734 | €221,756 | +€126,022 | +132% |
| Other amounts receivable | 41 | €15,156 | €4,952 | -€10,204 | -67.3% |
| Current investments | 50/53 | €234,113 | €232,897 | -€1,217 | -0.5% |
| Cash at bank and in hand | 54/58 | €111,641 | €175,280 | +€63,639 | +57.0% |
| Deferred charges and accrued income | 490/1 | €441 | €464 | +€23 | +5.2% |
| Total equity and liabilities | 10/49 | €470,526 | €641,701 | +€171,175 | +36.4% |
| Equity | 10/15 | €447,392 | €428,324 | -€19,068 | -4.3% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €445,892 | €426,824 | -€19,068 | -4.3% |
| Distributable reserves | 133 | €445,892 | €426,824 | -€19,068 | -4.3% |
| Amounts payable | 17/49 | €23,134 | €213,378 | +€190,244 | +822% |
| Amounts payable within one year | 42/48 | €8,141 | €213,378 | +€205,237 | +2,521% |
| Trade debts | 44 | €1,028 | €4,583 | +€3,555 | +346% |
| Suppliers | 440/4 | €1,028 | €4,583 | +€3,555 | +346% |
| Taxes, remuneration and social security | 45 | €6,522 | €41,756 | +€35,234 | +540% |
| Taxes | 450/3 | €6,522 | €41,756 | +€35,234 | +540% |
| Other amounts payable | 47/48 | €591 | €167,039 | +€166,448 | +28,181% |
| Accrued charges and deferred income | 492/3 | €14,993 | - | -€14,993 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,208 | €7,367 | -€4,841 | -39.7% |
| Other operating charges | 640/8 | €1,466 | €911 | -€555 | -37.9% |
| Gross operating margin | 9900 | €385,194 | €565,866 | +€180,672 | +46.9% |
| Operating profit (loss) | 9901 | €371,520 | €557,588 | +€186,068 | +50.1% |
| Financial income | 75/76B | €8,776 | €5,845 | -€2,931 | -33.4% |
| Recurring financial income | 75 | €8,776 | €5,845 | -€2,931 | -33.4% |
| Financial charges | 65/66B | €159 | €218 | +€59 | +36.9% |
| Recurring financial charges | 65 | €159 | €218 | +€59 | +36.9% |
| Profit (loss) for the period before taxes | 9903 | €380,136 | €563,215 | +€183,079 | +48.2% |
| Income taxes | 67/77 | €90,319 | €136,391 | +€46,073 | +51.0% |
| Profit (loss) for the period | 9904 | €289,818 | €426,824 | +€137,006 | +47.3% |
| Profit (loss) for the period to be appropriated | 9905 | €289,818 | €426,824 | +€137,006 | +47.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.